121 related articles for article (PubMed ID: 35157992)
1. Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study.
Lindegaard JC; Petric P; Schmid MP; Nesvacil N; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Kirchheiner K; Spampinato S; Jürgenliemk-Schulz I; Tanderup K; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):379-389. PubMed ID: 35157992
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a New Prognostic Tumor Score in Locally Advanced Cervical Cancer Integrating Clinical Examination and Magnetic Resonance Imaging.
Lindegaard JC; Petric P; Lindegaard AM; Tanderup K; Fokdal LU
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):754-763. PubMed ID: 31794837
[TBL] [Abstract][Full Text] [Related]
3. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
4. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract][Full Text] [Related]
5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
6. Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer.
Palhares DMF; Marconi DG; Azevedo TL; Hess CB; Fregnani JHTG; Affonso RJ; Veneziani ACLC; Canton HP; Gadia R; Spadim MD; Rossini RR; Kamrava M
Brachytherapy; 2018; 17(6):935-943. PubMed ID: 30100273
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
9. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C;
J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120
[TBL] [Abstract][Full Text] [Related]
11. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
12. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
14. Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive Brachytherapy.
Schernberg A; Bockel S; Annede P; Fumagalli I; Escande A; Mignot F; Kissel M; Morice P; Bentivegna E; Gouy S; Deutsch E; Haie-Meder C; Chargari C
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):362-372. PubMed ID: 29920324
[TBL] [Abstract][Full Text] [Related]
15. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
16. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
[TBL] [Abstract][Full Text] [Related]
17. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
[TBL] [Abstract][Full Text] [Related]
18. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
[TBL] [Abstract][Full Text] [Related]
19. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
20. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
